Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Johnson & Johnson Guidance Holds Firm Amid Second-Quarter Update

Guavy AI Editorial Team
Instruments
JNJ
Share

Johnson & Johnson's (US4781601046) stock price held steady following its updated guidance for full-year 2026, which remains unchanged at $93.2 billion to $93.6 billion in sales and adjusted EPS of $10.80 to $10.90.

The company's second-quarter 2026 sales reached $23.7 billion, while adjusted EPS came in at $2.77, setting the tone for the back half of the year.

Johnson & Johnson's product mix remains anchored by pharmaceuticals and medical technology, with the former carrying the most weight in the earnings narrative.

More on Stocks

Stocks 1m ago

US Labor Market Decelerates in September, Disappointing Investors

Stocks 10m ago

Disney Expands Dreamers Academy Through Boys & Girls Clubs Partnership

Stocks 10m ago

Disney Dreamers Academy Expands Program with Boys & Girls Clubs Partnership

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy